PFIZER INC.
- Country
- 🇺🇸United States
- Ownership
- Public
- Established
- 1849-01-01
- Employees
- 88K
- Market Cap
- $163.3B
- Website
- http://www.pfizer.com
Effect of Multiple Doses of Itraconazole on the Pharmacokinetics of a Single-Dose of PF-06651600 in Healthy Participants
- Conditions
- Healthy Participants
- Interventions
- Drug: PF-06651600 10 mg tablets
- First Posted Date
- 2019-01-29
- Last Posted Date
- 2019-06-28
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT03821493
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Be-bru, Belgium
A Study of Adverse Events and Suspected Adverse Drug Reactions of Patients Under Treatment of Apixaban for Venous Thomboembolism (VTE) Treatment
- Conditions
- Thrombosis, Deep VeinPulmonary Embolism
- First Posted Date
- 2019-01-23
- Last Posted Date
- 2021-11-11
- Lead Sponsor
- Pfizer
- Registration Number
- NCT03812835
Study of PF-04965842 Effect on Rosuvastatin Pharmacokinetics in Healthy Participants
- First Posted Date
- 2019-01-16
- Last Posted Date
- 2019-05-06
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT03806101
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium
A Study of Adverse Events and Suspected Adverse Drug Reactions in Patients Under Apixaban for Prevention of Stroke and Systemic Embolism With Non-Valvular Atrial Fibrillation and Venous Thromboembolic Events in Patients Who Have Undergone Elective Hip or Knee Replacement Surgery
- Conditions
- Pulmonary EmbolismCerebral StrokeThrombosis, Deep Vein
- First Posted Date
- 2019-01-15
- Last Posted Date
- 2021-11-22
- Lead Sponsor
- Pfizer
- Registration Number
- NCT03804125
Observational, Real World Study Of Inflectra In Patients With Inflammatory Bowel Disease
- Conditions
- Inflammatory Bowel Disease (IBD)Crohn's Disease (CD)Ulcerative Colitis (UC)
- Interventions
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2021-03-02
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 118
- Registration Number
- NCT03801928
- Locations
- 🇺🇸
San Diego Clinical Trials, San Diego, California, United States
🇺🇸Medical Research Center Of Connecticut, LLC, Hamden, Connecticut, United States
🇨🇦Montreal IBD Center (CMIIM), Montreal, Quebec, Canada
Bioequivalence Study of Tramadol Hydrochloride /Paracetamol Tablets Versus Ultracet Tablets
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-01-14
- Last Posted Date
- 2019-07-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 60
- Registration Number
- NCT03803371
- Locations
- 🇧🇷
ICF - Instituto de Ciencias Farmaceuticas de Estudos e Pesquisas Ltda, Aparecida de Goiania, GO, Brazil
JAK1 Inhibitor With Medicated Topical Therapy in Adolescents With Atopic Dermatitis
- Conditions
- Atopic Dermatitis
- Interventions
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2022-04-13
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 287
- Registration Number
- NCT03796676
- Locations
- 🇺🇸
UC Davis, Sacramento, California, United States
🇺🇸AdventHealth Orlando, Orlando, Florida, United States
🇺🇸Madera Family Medical Group, Madera, California, United States
Study of PF 04965842 Effect on MATE1/2K Activity in Healthy Participants
- First Posted Date
- 2019-01-08
- Last Posted Date
- 2020-02-05
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 12
- Registration Number
- NCT03796182
- Locations
- 🇧🇪
Pfizer Clinical Research Unit, Brussels, Belgium
Observational Study Investigating Clinical & Anthropometric Characteristics of Children With Achondroplasia.
- Conditions
- Achondroplasia
- First Posted Date
- 2019-01-07
- Last Posted Date
- 2024-10-17
- Lead Sponsor
- Pfizer
- Target Recruit Count
- 315
- Registration Number
- NCT03794609
- Locations
- 🇺🇸
Los Angeles BioMedical Research Institute at Harbor-UCLA Medical Center, Torrance, California, United States
🇺🇸Texas Children Hospital, Houston, Texas, United States
🇺🇸Boston Childrens Hospital, Boston, Massachusetts, United States
A Study Of Duloxetine Hydrochloride Hard Gelatinous Capsule Compared To Cymbalta Under Fed Conditions
- Conditions
- Healthy
- Interventions
- First Posted Date
- 2019-01-04
- Last Posted Date
- 2019-09-27
- Lead Sponsor
- Pfizer
- Registration Number
- NCT03794154